Italian government proposals for healthcare:
This article was originally published in Clinica
The Italian government intends to allocate some Lit 100,000 billion ($55 billion) a year to healthcare under its National Health Plan for 1998-2000. The parliament has yet to approve the plan. Its measures are aimed at achieving a 10% cut in mortality due to cancer and to cardiovascular, cerebrovascular and infectious diseases, as well as better care for at-risk sections of the population, such as children and the elderly, people with mental illness and drug addicts.
You may also be interested in...
A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Samsung Bioepis is the latest company to stare down a lawsuit from Genentech over Avastin patents in the US. The Korean firm is aiming to be amongst the early biosimilar movers, after the market formed a year ago.